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Edited by Lev KisselevAbstract Nonsense-mediated mRNA decay (NMD) is one of
the mRNA surveillance mechanisms, which eliminates aberrant
mRNAs harboring premature termination codons. NMD targets
only mRNAs bound by the nuclear cap-binding protein complex
CBP80/20 which directs the pioneer round of translation. Here
we demonstrate that NMD occurs eﬃciently during prolonged
hypoxia in which steady-state translation is drastically inhibited.
Accordingly, CBP80 remains in the nucleus, and processing
bodies are unaﬀected with regard to their abundance and number
under prolonged hypoxic conditions. These results indicate that
mRNAs enter the pioneer round of translation during prolonged
hypoxia.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The gene expression pathway in mammalian cells involves a
number of highly coordinated events. These include transcrip-
tion, splicing, mRNA export from the nucleus to the cyto-
plasm, and translation. In addition, mammalian cells have
evolved sophisticated mRNA quality control mechanisms that
ensure the ﬁdelity of gene expression by recognizing and
degrading faulty mRNAs [1]. One of the best characterized
mRNA quality control mechanisms thus far is the nonsense-
mediated mRNA decay (NMD), which rids the cells of
mRNAs that harbor premature termination codons (PTCs)
[2,3]. By so doing, NMD eliminates the production of the trun-
cated form of the protein, which could be deleterious to cells.
Within the cells, PTCs can arise in transcripts as a consequence
of somatic mutations, errors in transcription, inaccurate or
ineﬃcient splicing, failure to incorporate selenocysteine at spe-
ciﬁc UGA codons of some selenoprotein mRNAs, or alterna-
tive splicing [2,3].
NMD is preceded by the pioneer round of translation which
occurs on newly synthesized mRNAs bound by the heterodi-
mer of the nuclear cap-binding proteins 80/20 (CBP80/20) to
the 5 0-end cap structure. During the pioneer round of transla-*Corresponding author.
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doi:10.1016/j.febslet.2007.10.002tion, translating ribosomes along the mRNAs displace exon
junction complexes (EJCs) deposited onto mRNA as a conse-
quence of the splicing event. Following the completion of the
pioneer round of translation initiation, CBP80/20 is replaced
by the major cytoplasmic cap-binding protein eIF4E, which di-
rects steady-state translation initiation. Thus, the pioneer
round of translation diﬀers from steady-state translation in
the following ways [4–6]. First, the pioneer round of transla-
tion occurs on newly spliced, EJC- and CBP80/20-bound
mRNAs, whereas steady-state translation occurs on EJC-free
and eIF4E-bound mRNAs. Second, the pioneer round of
translation occurs during mRNA export through the nuclear
pore complex, whereas steady-state translation occurs in the
cytoplasm. Third, steady-state translation allows for a rapid
response to alterations in physiological conditions and envi-
ronmental stresses [7–10]. With regard to speciﬁcally the pio-
neer round of translation, however, few studies regarding its
control under stressful conditions have been conducted thus
far.
In this study, we have attempted to determine whether the
pioneer round of translation and its consequent event NMD
are controlled by cellular stresses, and also have attempted
to ascertain the fate of mRNAs synthesized under such stress
conditions. In order to answer these questions, we have as-
sessed the eﬃciency of NMD, which targets the mRNA bound
by CBP80/20 but not eIF4E, under prolonged hypoxic condi-
tions in which steady-state translation is blocked to a signiﬁ-
cant degree [7,8,10,11]. We show that both nucleus-
associated and cytoplasmic NMD occur eﬃciently under pro-
longed hypoxic conditions. These results indicate that NMD
and its upstream event, the pioneer round of translation, occur
eﬃciently under prolonged hypoxic conditions, so as to recog-
nize and degrade aberrant mRNAs. In support of this notion,
we also demonstrate that a component of the major nuclear
cap-binding protein, CBP80, is highly localized to the nucleus,
and that the size and numbers of processing bodies remain
unaltered under prolonged hypoxic conditions. On the other
hand, eIF4E is redistributed into the nucleus under prolonged
hypoxic conditions.2. Materials and methods
2.1. Cell culture, transfections, and protein and RNA puriﬁcation
The cultivation of HeLa cells and plasmid transfection were per-
formed as previously described [12]. One day after transfection, cells
were grown either under normoxic conditions (20.9% O2, 5.0% CO2)
or placed in a hypoxic chamber (0.1% O2, 5.0% CO2) for 12 h. Total
proteins and RNAs were prepared as previously reported [13].blished by Elsevier B.V. All rights reserved.
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Endogenous SMG7, FLuc, b-Gl, GPx1, and MUP mRNAs
were ampliﬁed as described previously [4,6,12]. In brief, semi-
quantitative RT-PCR was performed using speciﬁc primer sets and
a-[32P]-dATP. As a control for the variation of RNA extraction
and sample loading, endogenous SMG7 mRNA was ampliﬁed
simultaneously. Labeled PCR products were electrophoresed in 5%
polyacrylamide gel, visualized by PhosphorImaging (BAS-2500;
Fuji Photo Film Co.), and then quantitated by Multigauge (Fuji
Photo Film Co.). A standard curve of intensity versus RNA
amount was prepared using 2-fold serial dilutions of puriﬁed RNAs,
and then the relative amounts of PCR products were determined from
the curve.
Dual luciferase assays were performed as previously described
[4,6,12].
2.3. Western blotting
Western blotting was conducted as described previously [13]. The
antibodies used in this study recognized Upf1, Upf2, Upf3X (gifts
from Dr. Lynne E. Maquat), CBP80 [14], eIF4AIII [15], HIF-1a (a gift
from Dr. Sung-Gil Chi), eIF4E (Cell Signaling), eIF4GI [16], eIF4AI
(Abcam), eIF3 (a gift from Dr. John W. Hershey), eIF2a (Cell Signal-
ing), Phospho-eIF2a (Ser51) (Cell Signaling), eIF4E-BP1 (This anti-
body recognizes both phosphorylated and dephosphorylated form ofB
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Fig. 1. Prolonged hypoxia reduces the eﬃciency of steady-state translation. H
(see text for the details). One day after transfection, cells were either grown un
Semi-quantitative RT-PCR of FLuc and endogenous SMG7 mRNAs. The fo
demonstrate that the RT-PCR is semi-quantitative. The numbers below the p
of endogenous SMG7 mRNA. (B) Relative FLuc activities. FLuc activity wa
was normalized to the level of the relative FLuc mRNA.eIF4E-BP1; Cell Signaling), Phospho-eIF4E-BP1 (Ser65/Thr70) (Santa
Cruz), and b-actin (Sigma).
2.4. Immunoﬂuorescence
Immunostaining were performed as previously described [12]. The
antibodies used in this study recognized FLAG tag (Sigma), eIF4E
(BD Bioscience), and eIF4GI. The primary antibodies were detected
using rhodamine- or ﬂuorescein-conjugated secondary antibodies
(Pierce). The nuclei were stained with DAPI (Biotium Inc.). Cells were
observed with a ZEISS confocal microscope (LSM510 META). When
indicated, HeLa cells were transiently transfected with 2 lg of
pCDNA3-FLAG-Dcp1a [17] or pCDNA3-FLAG-CBP80 [12] using
Lipofectamine 2000 (Invitrogen).3. Results
3.1. Steady-state translation, but not the pioneer round of
translation, is drastically inhibited during prolonged
hypoxia
In order to characterize the eﬀects of prolonged hypoxia on
the pioneer round of translation and steady-state translation,R
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eLa cells were transiently transfected with a combination of plasmids
der normoxic conditions or placed into a hypoxic chamber for 12 h. (A)
ur leftmost lanes represent 2-fold serial dilutions of puriﬁed RNAs and
anel represent the level of FLuc mRNA after normalization to the level
s normalized to the level of total protein. (C) The relative FLuc activity
5160 N. Oh et al. / FEBS Letters 581 (2007) 5158–5164we assessed the activities of ﬁreﬂy luciferase (FLuc), which are
reﬂective of steady-state translation, and NMD eﬃciencies,
which are reﬂective of the eﬃciency of the pioneer round of
translation. HeLa cells were co-transfected with four plasmids:
(i) the pGL3-control reporter plasmid which encodes FLuc
cDNA and provides a measure of steady-state translation;
(ii) a pmCMV-Gl test plasmid [18] that is either nonsense-free
(Norm) or contains a PTC at the 39th amino acid position
(39Ter) of the globin gene (Gl), which provides an assay for
nucleus-associated NMD; (iii) the pmCMV-GPx1 test plasmid
[19], either Norm or 46Ter, which provides an assay for cyto-
plasmic NMD; and (iv) the phCMV-MUP reference plasmid
[20], which controls for variations in the eﬃciencies of transfec-
tion and RNA recovery. One day after transfection, the cells
were either grown under normoxic conditions or placed in a
hypoxic chamber for 12 h. Total-cell proteins and RNAs were
puriﬁed, after which luciferase assays and semi-quantitative
RT-PCR analyses were conducted in order to measure the
abundance of the FLuc protein and FLuc mRNA, respec-
tively.
The results showed that the relative level of FLuc mRNA
was slightly increased in abundance under prolonged hypoxic
conditions, by 1.6-fold (Fig. 1A). In contrast, the relative FLuc
activity was reduced by 3-fold under the hypoxic conditions
(Fig. 1B). The ratio of relative FLuc activity to relative FLuc
mRNA, which provides a measure of steady-state translation,
showed that steady-state translation was inhibited drastically,
by 5-fold, under prolonged hypoxic conditions (Fig. 1C).
Using the same total RNAs as were employed in the above
experiment, the eﬃciency of the pioneer round of translation
was assessed by measuring both the nucleus-associated
NMD of globin and the cytoplasmic NMD of GPx1 mRNAs
(Fig. 2). The PTC within Gl mRNA has been shown to reduce
the half-life of Gl mRNA copuriﬁed with nuclei [21]. While
most mRNAs harboring PTCs are targeted for nucleus-associ-
ated NMD, GPx1 mRNA harboring PTC undergoes the cyto-
plasmic NMD [19]. Notably, both nucleus-associated and
cytoplasmic NMD target the newly synthesized mRNAs
bound by CBP80/20 [5].A
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Fig. 2. NMD occurs during prolonged hypoxia. As in Fig. 1, except that the
PCR. The level of Gl or GPx1 mRNA was normalized to the level of MUP mUnder normoxic conditions, the abundances of globin
mRNAs harboring 39Ter and GPx1 mRNAs harboring
46Ter were reduced to approximately 8% and 34% of the nor-
mal mRNAs, respectively. Interestingly, the abundances of
globin and GPx1 mRNAs harboring PTC were reduced to
approximately 9% and 40%, respectively, under prolonged
hypoxic conditions, thereby indicating that both types of
NMDs occurred eﬃciently under prolonged hypoxic condi-
tions. Considering that both nucleus-associated and cytoplas-
mic NMD targets the mRNA bound by CBP80/20 but not
eIF4E in mammalian cells, these results show that the pioneer
round of translation occurs eﬃciently during prolonged hy-
poxia.
3.2. The levels of cellular factors involved in the pioneer round of
translation and NMD do not diﬀer between normoxic and
prolonged hypoxic conditions
In order to gain greater insight into the pioneer round of
translation and NMD under prolonged hypoxic conditions,
we evaluated the levels of the cellular proteins involved in these
processes. These include CBP80, the key NMD factors, Upf1,
Upf2, and Upf3X, and the core EJC component, eIF4AIII.
Hypoxia-inducible transcription factor 1a (HIF-1a), which is
induced during hypoxia, was also included in our analysis
(Fig. 3A).
The results of Western blotting indicated that HIF-1a was
drastically induced under prolonged hypoxic conditions for
12 h. Other tested proteins, however, evidenced no signiﬁcant
diﬀerences in abundance under both normoxic and prolonged
hypoxic conditions (Fig. 3A), which is consistent with our ﬁnd-
ing that NMD occurred eﬃciently under prolonged hypoxic
conditions (Fig. 2).
Hypoxia has been shown to induce a biphasic inhibition of
steady-state translation [8,11]. The initial inhibition (i.e.
15 min – 4 h) is primarily dependent on eIF2a phosphoryla-
tion, whereas inhibition during prolonged hypoxia occurs
independently of eIF2a. Instead, the inhibition of translation
during prolonged hypoxia is associated with sequestration of
eIF4E by both dephosphorylated eIF4E-BP1 and eIF4E-T.pmCMV-GPx1
GPx1 mRNA
MUP mRNA
GPx1 mRNA
(% of Norm)1
00
10
034
± 
0
40
± 
0
N
or
m
46
Te
r
N
or
m
46
Te
r
H
yp
ox
ia
N
or
m
ox
ia
levels of Gl mRNA (A) and GPx1 mRNA (B) were analyzed by RT-
RNA. Normalized levels of each Norm mRNA were deﬁned as 100%.
Upf3X
CBP80
eIF4AIII
N
or
m
ox
ia
H
yp
ox
iaA
Upf2
HIF-1α
Upf1
β-actin
N
or
m
ox
ia
H
yp
ox
ia
eIF2α
Phospho-eIF2α
eIF4E
Phospho-eIF4E-BP1
β-actin
eIF4GI
Phospho-eIF4E-BP1
eIF4E-BP1
eIF4AI
a
b/c
e/f
g
i/j
eIF3
B
d
Fig. 3. Prolonged hypoxia does not alter the levels of the cellular factors involved in NMD or the pioneer round of translation. (A) As in Fig. 1,
except that total proteins were analyzed with indicated antibodies using Western blotting. b-actin served as a loading control. The three leftmost
lanes, in which 3-fold serial dilutions of cellular proteins were analyzed, demonstrate that the conditions used for Western blotting are semi-
quantitative. (B) As in (A), except that initiation factors involved in steady-state translation were analyzed.
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phosphorylation and the abundance of eIF4E-BP1 and eIF2a.
The results of Western blotting revealed that the abundances
of the general translation initiation factors, eIF4E, eIF4GI, eI-
F4AI, eIF3, and eIF2a, did not change signiﬁcantly under pro-
longed hypoxic conditions. Notably, eIF2a, which has been
shown to be phosphorylated during acute hypoxia, was
dephosphorylated under prolonged hypoxic conditions
(Fig. 3B). Furthermore, the dephosphorylated but not the
phosphorylated form of eIF4E-BP1 increased signiﬁcantly in
its abundance. Considering that dephosphorylated eIF4E-
BP1 sequesters eIF4E competing with eIF4GI/II for binding
to eIF4E [9], these results indicate that increased quantities
of dephosphorylated eIF4E-BP1 sequesters eIF4E during pro-
longed hypoxia.
Collectively, our results show that hypoxia preferentially
inhibits steady-state translation, but not the pioneer round of
translation. It follows, then, that PTC-harboring mRNAs
can be targeted for NMD under prolonged hypoxic conditions.
3.3. The localization of CBP80 and the number and size of P-
bodies are unaﬀected, whereas eIF4E is redistributed into
the nucleus during hypoxia
The exposure of mammalian cells to environmental stresses
triggers the formation of discrete and highly dynamic cytoplas-mic foci, which are referred to as stress granules. By so doing,
eukaryotic cells modulate the eﬃciency of steady-state transla-
tion in order to adapt to stressful conditions [22,23].
In addition to stress granules, the large mRNP complex,
which is referred to as the processing bodies (P-bodies), has
been observed in both lower and higher eukaryotic cells. P-
bodies store translationally repressed mRNAs and represent
cellular mRNA degradation sites [22,23].
We attempted to determine whether CBP80 or eIF4E local-
izes to stress granules or P-bodies under prolonged hypoxic
conditions. To this end, HeLa cells were transfected with plas-
mid pcDNA3-FLAG-CBP80 to express FLAG-tagged CBP80.
One day after transfection, the cells were grown either under
normoxic conditions or placed into a hypoxic chamber for
12 h, after which the intracellular locations of FLAG-CBP80
and endogenous eIF4E were determined via immunoﬂuores-
cence microscopy.
FLAG-CBP80 was signiﬁcantly enriched in the nucleus,
regardless of hypoxic conditions (Fig. 4A). On the other
hand, endogenous eIF4E was mainly detected in the cytoplasm
under normoxic conditions, and was redistributed from the
cytoplasm to the nucleus during hypoxia (Fig. 4B), which is
consistent with the previous report [11]. Endogenous eIF4GI,
which localizes to stress granules under stress conditions, was
evenly dispersed in the cytoplasm under normoxic conditions,
Fig. 4. Prolonged hypoxia does not aﬀect the distribution of CBP80 and the formation of P-bodies. (A) FLAG-CBP80 under normoxic or prolonged
hypoxic conditions was visualized by a-FLAG antibody. Nuclei were stained by DAPI. (B) Endogenous eIF4E and eIF4GI were visualized by
a-eIF4E antibody and a-eIF4GI antibody, respectively. (C) As in (A), except that FLAG-Dcp1a was visualized.
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(Fig. 4B). Considering that we failed to detect any increase
in eIF2a phosphorylation (Fig. 3B) which is a prerequisite
for the formation of stress granules, these results show thatprolonged hypoxia cannot induce the formation of stress
granules.
FLAG-tagged Dcp1a, which is a marker protein for P-body,
was utilized in order to characterize the eﬀects of prolonged
N. Oh et al. / FEBS Letters 581 (2007) 5158–5164 5163hypoxia on the formation of P-bodies. The overall number and
size of P-bodies per cell under normoxic conditions were al-
most equal to those observed under prolonged hypoxic condi-
tions (Fig. 4C).
These data collectively suggest that, whereas steady-
state translation is drastically inhibited as the result of the
redistribution of eIF4E into the nucleus, the pioneer
round of translation occurs eﬃciently during prolonged
hypoxia and, in turn, NMD eﬃciently targets aberrant tran-
scripts.4. Discussion
In this work, we present compelling evidence to show that the
pioneer round of translation occurs eﬃciently during prolonged
hypoxia, in which steady-state translation is abolished. Conse-
quently, NMD, which is preceded by the pioneer round of
translation, eﬃciently recognizes and degrades aberrant tran-
scripts harboring PTC under prolonged hypoxic conditions.
Our data shed light on the crucial role of the pioneer round
of translation and NMD in mRNA surveillance under stressful
conditions. It has been known that a variety of environmental
stresses modulate the splicing process [24–26]. For instance,
splicing is generally repressed by severe heat shock [27–29].
Hypoxia can trigger exon skipping via the induction of
HMGA1a, which could interfere with U1 snRNP binding to
the 5 0 splice site [30,31]. In addition, stress induces the appear-
ance of abnormal transcripts in primary lymphocytes [32]. Im-
paired splicing machinery or stress-induced alternative splicing
tends to generate aberrant transcripts that harbor PTC. Con-
sidering our results indicating that the pioneer round of trans-
lation and NMD occur eﬃciently under stress conditions, we
can speculate that NMD machinery recognizes and degrades
the aberrant transcripts generated during stress, thereby ensur-
ing cell survival during or after stress.
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